NCT03749850 2021-02-17
i-GO
UMC Utrecht
Phase 1 Unknown
Clinical Trials
7 trialsNCT03547388 2020-05-05
GKH-TMM
Charite University, Berlin, Germany
Phase 1 Completed
NCT00441376 2019-02-07
A Study of ThermoDoxâ„¢ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver
Imunon
Phase 1 Completed
NCT02093871 2017-07-21
PISH-2
ThermalCore Inc
Phase 1 Suspended
NCT00001576 2008-03-04
A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00001577 2008-03-04
Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00001587 2008-03-04
A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver
National Institutes of Health Clinical Center (CC)
Phase 1 Completed